These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35813301)

  • 1. Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.
    Chung JF; Chen CL; Nassef Y; Shiu BH; Wang CH; Kuo FH; Hsiao YH; Yang SF; Wang PH
    Int J Med Sci; 2022; 19(6):1013-1022. PubMed ID: 35813301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
    Ng SC; Wang PH; Lee YC; Lee CY; Yang SF; Shen HP; Hsiao YH
    Int J Med Sci; 2019; 16(6):774-782. PubMed ID: 31337950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients.
    Sun YH; Wang CM; Shen HP; Lee CY; Lin CW; Yang SF; Wang PH
    Int J Med Sci; 2024; 21(8):1428-1437. PubMed ID: 38903932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of genetic variant distributions of WW domain-containing oxidoreductase gene with uterine cervical cancer.
    Lin YH; Hsiao YH; Wu WJ; Yang SF; Hsu CF; Kang YT; Wang PH
    Int J Med Sci; 2018; 15(10):1005-1013. PubMed ID: 30013442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of metastasis-associated in colon cancer-1 genetic variants in the development and clinicopathologcial characteristics of uterine cervical cancer in Taiwanese women.
    Sun YH; Chou YH; Ou CC; Ng SC; Shen HP; Lee YC; Hsu CF; Yang SF; Wang PH
    Int J Med Sci; 2020; 17(4):490-497. PubMed ID: 32174779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
    Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
    Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Clinicopathological Characteristics and Tissue Inhibitor of Metalloproteinase-3 Polymorphism Rs9619311 on Biochemical Recurrence in Taiwanese Patients with Prostate Cancer.
    Hsieh CY; Lin CY; Wang SS; Chou YE; Chien MH; Wen YC; Hsieh MJ; Yang SF
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of
    Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of
    Sun YH; Chou YH; Wang CH; Hsiao YH; Lee CY; Yang SF; Wang PH
    Int J Med Sci; 2021; 18(11):2339-2346. PubMed ID: 33967610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.
    Wu PJ; Wang CH; Hsieh MH; Lee CY; Wang PH; Lin CW; Yang SF; Lee MS
    Int J Med Sci; 2021; 18(11):2457-2465. PubMed ID: 33967624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women.
    Tsai HT; Hsieh MJ; Chiou HL; Lee HL; Hsin MC; Liou YS; Yang CC; Yang SF; Kuo WH
    Tumour Biol; 2014 Sep; 35(9):8999-9007. PubMed ID: 24903383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.
    Su CW; Huang YW; Chen MK; Su SC; Yang SF; Lin CW
    Medicine (Baltimore); 2015 Nov; 94(46):e2092. PubMed ID: 26579821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms and haplotypes of membrane type 1-matrix metalloproteinase in susceptibility and clinical significance of squamous cell neoplasia of uterine cervix in Taiwan women.
    Tee YT; Liu YF; Chang JT; Yang SF; Chen SC; Han CP; Wang PH; Liao CL
    Reprod Sci; 2012 Sep; 19(9):932-8. PubMed ID: 22527983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationships of genetic polymorphisms of the long noncoding RNA growth arrest-specific transcript 5 with uterine cervical cancer.
    Weng SL; Ng SC; Lee YC; Hsiao YH; Hsu CF; Yang SF; Wang PH
    Int J Med Sci; 2020; 17(9):1187-1195. PubMed ID: 32547314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single nucleotide polymorphisms and haplotypes of carbonic anhydrase 9 can predict invasive squamous cell carcinoma of uterine cervix.
    Shen HP; Hsiao YH; Yang SF; Liu YF; Ko JL; Wang PH
    Int J Med Sci; 2018; 15(6):587-594. PubMed ID: 29725249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Nucleotide Polymorphisms and Haplotypes of Intercellular Adhesion Molecule-1 in Uterine Cervical Carcinogenesis in Taiwanese Women.
    Sun YH; Yang SF; Liu YF; Ko JL; Wu CH; Wu TF; Wang PH
    Reprod Sci; 2016 Mar; 23(3):401-8. PubMed ID: 26377999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of tissue inhibitor of metalloproteinases-3 genetic variants on clinicopathological characteristics of urothelial cell carcinoma.
    Weng WC; Hsieh MH; Chiou HL; Lee CY; Tang CH; Chang LC; Wang SS; Yang SF
    J Cancer; 2023; 14(3):360-366. PubMed ID: 36860920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinicopathological characteristic associations of long non-coding RNA gene H19 polymorphisms with uterine cervical cancer.
    Huang MC; Chou YH; Shen HP; Ng SC; Lee YC; Sun YH; Hsu CF; Yang SF; Wang PH
    J Cancer; 2019; 10(25):6191-6198. PubMed ID: 31772651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant association of long non-coding RNAs HOTAIR genetic polymorphisms with cancer recurrence and patient survival in patients with uterine cervical cancer.
    Weng SL; Wu WJ; Hsiao YH; Yang SF; Hsu CF; Wang PH
    Int J Med Sci; 2018; 15(12):1312-1319. PubMed ID: 30275757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Genetic Polymorphisms of WNT1 Inducible Signaling Pathway Protein 1 and Uterine Cervical Cancer.
    Lin YH; Hsiao YH; Yang SF; Liu YF; Hsu CF; Wang PH
    Reprod Sci; 2018 Nov; 25(11):1549-1556. PubMed ID: 29402200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.